טוען...
IL-2-driven CD8(+) T cell phenotypes: implications for immunotherapy
The therapeutic potential of interleukin (IL)-2 in cancer treatment has been known for decades, yet its widespread adoption in clinical practice remains limited. Recently, chimeric proteins of an anti-PD-1 antibody and suboptimal IL-2 variants were shown to stimulate potent antitumor and antiviral i...
שמור ב:
| הוצא לאור ב: | Trends Immunol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2023
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615502/ https://ncbi.nlm.nih.gov/pubmed/37827864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2023.09.003 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|